Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Transplantation|October 24, 2008
Operational tolerance in nonvascularized transplant models induced by AR-C117977, a monocarboxylate transporter inhibitorClara Påhlman, Helene Malm, Zhongquan Qi, et al.
Annals of Surgery|November 28, 2002
Fundamental and distinct roles of P-selectin and LFA-1 in ischemia/reperfusion-induced leukocyte-endothelium interactions in the mouse colonAmjid Ali Riaz, Ming Xiu Wan, Thilo Schaefer, et al.
Clinical Transplantation|September 18, 2009
Acute rejection in low-toxicity regimens: clinical impact and risk factors in the Symphony studyUlrich Frei, Pierre Daloze, Stefan Vítko, et al.
Transplantation|May 9, 2009
A randomized, doubleblind, placebo-controlled, study of single-dose rituximab as induction in renal transplantationGunnar Tydén, Helena Genberg, Jan Tollemar, et al.
Transplantation|July 23, 2002
Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient miceMatthias Corbascio, Harish Mahanty, Cecilia Osterholm, et al.
Transplantation|May 15, 2007
Anti-LFA-1 improves pig islet xenograft function in diabetic mice when long-term acceptance is induced by CTLA4Ig/anti-CD40LMakiko Kumagai-Braesch, Henrik Ekberg, Feng Wang, et al.
Clinical Pharmacokinetics|July 2, 2009
Mycophenolic acid exposure after administration of mycophenolate mofetil in the presence and absence of cyclosporin in renal transplant recipientsDirk R Kuypers, Henrik Ekberg, Josep Grinyó, et al.
Transplant Immunology|August 17, 2002
CTLA4Ig combined with anti-LFA-1 prolongs cardiac allograft survival indefinitelyMatthias Corbascio, Helene Ekstrand, Cecilia Osterholm, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 3, 2015
Risk Stratification for Rejection and Infection after Kidney TransplantationPietro E Cippà, Marc Schiesser, Henrik Ekberg, et al.
Transplantation|April 23, 2009
Health-related quality of life of patients receiving low-toxicity immunosuppressive regimens: a substudy of the Symphony StudyFederico Oppenheimer, Pablo Rebollo, Josep M Grinyo, et al.
Pageof 6